Lin‐Kun An
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Cancer therapeutics and mechanisms 33
- Synthesis and bioactivity of alkaloids 7
- Advanced biosensing and bioanalysis techniques 7
- DNA and Nucleic Acid Chemistry 6
- RNA Interference and Gene Delivery 5
-
- Synthesis and Biological Evaluation 10
- Synthesis and biological activity 6
- Co-authors
- Zhi‐Shu Huang (27 shared papers)Lian‐Quan Gu (26 shared papers)Shi‐Liang Huang (10 shared papers)Yu Qian (15 shared papers)Ding Li (11 shared papers)Tian‐Miao Ou (8 shared papers)Jia‐Heng Tan (9 shared papers)Xianzhang Bu (11 shared papers)
- Journals
- European Journal of Medicinal Chemistry (13 papers)Journal of Medicinal Chemistry (6 papers)Tetrahedron (5 papers)Bioorganic Chemistry (5 papers)Bioorganic & Medicinal Chemistry (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lin‐Kun An
76 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 81
- Toxicology 197
- Pharmacology 289
- Organic Chemistry 536
- Molecular Biology 821
- Pharmacology 98
Countries citing papers authored by Lin‐Kun An
This map shows the geographic impact of Lin‐Kun An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Kun An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Kun An more than expected).
Fields of papers citing papers by Lin‐Kun An
This network shows the impact of papers produced by Lin‐Kun An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Kun An. The network helps show where Lin‐Kun An may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin‐Kun An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 108 | |
| 2 | 2017 | 92 | |
| 3 | 2008 | 60 | |
| 4 | 2008 | 55 | |
| 5 | 2010 | 55 | |
| 6 | 2010 | 54 | |
| 7 | 2018 | 43 | |
| 8 | 2010 | 41 | |
| 9 | 2010 | 38 | |
| 10 | 2013 | 37 | |
| 11 | 2016 | 37 | |
| 12 | 2015 | 36 | |
| 13 | 2017 | 35 | |
| 14 | 2010 | 35 | |
| 15 | 2007 | 34 | |
| 16 | 2018 | 33 | |
| 17 | 2012 | 33 | |
| 18 | 2020 | 29 | |
| 19 | 2006 | 29 | |
| 20 | 2002 | 27 |
About Lin‐Kun An
Lin‐Kun An is a scholar working on Molecular Biology, Organic Chemistry, Toxicology, Pharmacology and Oncology, having authored 78 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (33 papers), Bioactive Compounds and Antitumor Agents (21 papers), Synthesis and Biological Evaluation (10 papers), Synthesis and bioactivity of alkaloids (7 papers), Advanced biosensing and bioanalysis techniques (7 papers), Synthesis and biological activity (6 papers), DNA and Nucleic Acid Chemistry (6 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Toxicology (197 citations), Pharmacology (289 citations), Organic Chemistry (536 citations), Molecular Biology (821 citations) and Pharmacology (98 citations). Lin‐Kun An has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhi‐Shu Huang, Lian‐Quan Gu, Shi‐Liang Huang, Yu Qian, Ding Li, Tian‐Miao Ou, Jia‐Heng Tan, Xianzhang Bu, Huan Yan and Xu‐Jie Qin. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Tetrahedron, Bioorganic Chemistry and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.